Stratec Founder Weighs Options After Covid Boom

Stratec SE’s founder is exploring options for the German health-care technology provider that could include a potential sale, people familiar with the matter said. Hermann Leistner and his family have received preliminary private equity interest in their 40.55% stake, according to the people, who asked not to be identified discussing confidential information. Any deal for Leistner’s stake could trigger a bid for all of Stratec, which has a market value of 1.3 billion euros ($1.5 billion). Stratec shares rose as much as 11% on Monday. Deliberations are in the early stages, and there’s no certainty they’ll result in a transaction, the people said. A representative for Stratec declined to comment.